Glanbia (GLAPF) was Downgraded to a Hold Rating at Kepler Capital
Kepler Capital analyst Christian Nordby downgraded Glanbia (GLAPF) to Hold on April 7 and set a price target of EUR11.50. The company’s shares closed last Wednesday at $14.75.
Nordby has an average return of 33.0% when recommending Glanbia.
According to TipRanks.com, Nordby is ranked #1655 out of 7432 analysts.
Glanbia has an analyst consensus of Moderate Buy, with a price target consensus of $14.11.
See today’s analyst top recommended stocks >>
Glanbia’s market cap is currently $4.3B and has a P/E ratio of 25.00. The company has a Price to Book ratio of 10.15.
Based on the recent corporate insider activity of 18 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Glanbia Plc engages in the manufacture and distribution of dairy and nutritional ingredients. It operates through the following segments: Glanbia Performance Nutrition, Glanbia Nutritionals, Glanbia Ireland, and All Other. The Glanbia Performance Nutrition segment manufactures and sells performance nutrition products. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional ingredients. The Glanbia Ireland segment manufactures and sells cheese and dairy ingredients, and a range of consumer products from farm inputs. The All other segment includes both the results of other equity accounted investees who manufacture and sell cheese and dairy ingredients and unallocated corporate costs. The company was founded in 1997 and is headquartered in Kilkenny, Ireland.